Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Updated on: January 26,2024
21

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Updated on:January 26,2024
21
